News
WEF highlights AI shift in life sciences R&D
3+ hour, 23+ min ago (20+ words) AI is speeding up discovery but shifting bottlenecks to validation, regulatory approval, and large-scale deployment in complex healthcare systems....
Poly U collaborates with global scholars and experts to promote modern healthcare and wellness
1+ hour, 58+ min ago (455+ words) Close to 100 participants experience Taichi and Qigong They gathered leading academics, clinicians, and researchers from around the world to underscore the growing integration of these ancient mind-body practices into contemporary medical frameworks. The Symposium and Workshops integrated academic research with…...
Kotak Alts invests Rs 200 M in Cellogen Therapeutics
1+ hour, 11+ min ago (148+ words) May 18, 2026 | Monday | News Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to growth-stage life sciences and healthcare businesses, has made an investment of Rs 200 million in Delhi-based startup Cellogen…...
Astra Zeneca's blood pressure drug wins U. S. approval
3+ hour, 21+ min ago (47+ words) Published on 05/18/2026 at 02: 01 am EDT Astra Zeneca: Desirable start to 2026, but most strengths are already priced in April 29, 2026 at 09: 18 am EDT Astra Zeneca CFO on M&A Strategy and Obesity Market Astra Zeneca's CEO reportedly considers listing in the United…...
Which CRO Is Good at Protein Degradation?
40+ min ago (74+ words) Key Takeaways An ideal CRO for protein degradation combines discovery biology medicinal chemistry drug metabolism and pharmacokinetics DMPK and development expertise within an integrated platform Wu Xi App Tec helps innovators advance targeted protein degrader programs through coordinated discovery technologies…...
Algorae completes AI prediction phase for expanded drug combination program
6+ hour, 9+ min ago (262+ words) The program expands AOS2 from a single-anchor approach, previously centred on cannabidiol, to 18 anchor drugs, materially broadening the company's pipeline of AI-predicted drug combination opportunities." AOS2 evaluated more than nine"million potential drug-drug-cell line combinations, pairing 18 anchor drugs with thousands of approved…...
Hanmi Pharmaceutical Expands Obesity Drug Indication to Diabetes, Begins Phase 3 Dosing
1+ hour, 34+ min ago (86+ words) GLP-1 Class Drug 'Efpeglenatide' Phase 3 to Evaluate Combination Therapy's Blood Sugar Control Hanmi Pharmaceutical has begun dosing patients in a domestic Phase 3 clinical trial aimed at expanding the indication of its in-house developed glucagon-like peptide (GLP)-1 class new drug "efpeglenatide…...
CHEPLAPHARM ALIGNS ITS MANAGEMENT BOARD FOR NEXT PHASE OF GROWTH
2+ hour, 37+ min ago (236+ words) Cheplapharm SE/ Key word(s): Personnel CHEPLAPHARM ALIGNS ITS MANAGEMENT BOARD FOR NEXT PHASE OF GROWTH 18. 05. 2026 / 08: 45 CET/CEST Greifswald, May 18, 2026 In the newly created role of Chief Business & Strategy Officer (CBSO), Dr Keyarasch Parssanedjad will be responsible on the Management Board…...
Video. The rising threat of antimicrobial resistance and its economic toll
49+ min ago (235+ words) Euronews. com Video. The rising threat of antimicrobial resistance and its economic toll More people are expected to die every year from superbugs than cancer by 2050. Antibiotic resistance is "a major threat" to our health and economy, according to Japanese…...
The rising threat of antimicrobial resistance and its economic toll
49+ min ago (629+ words) We need new antibiotics," Estelle Fruchet, Shionogi Europe's General Manager for France urged. And while this might not sound like a particularly novel revelation, the stats behind her plea should have us all worried. In this episode of The Big…...